Myriad Making Good Deals (at Motley Fool)
                   
yahoo.com
23-May-2008 24 related
        

By Brian Lawler May 23, 2008 Comments (0) Some drug deals are better than others. Yesterday, Rule Breakers pick Myriad Genetics (Nasdaq: MYGN) announced a particularly strong partnership deal for its lead drug, Flurizan. Flurizan is currently in late-stage testing as a treatment for Alzheimer's... [read full story]                    

Add Comment
There are also 24 related articles
View all news articles about*:
A/S Advertising Alzheimer's Banking Behavior Bill Crime Crimes Disease Drug Finance Forest Genetics Health Insurance Investing Laboratories Lundbeck Mann Marketing Markets Mental Myriad Neurochem
*Newstin tag cloud displays all featured persons, associated organisations, related topics, regions and companies

View other selected articles:

                   

Sprenger + Lang, Terrell Marshall & Daudt and the Law Office of Kimberlee L. Gunning, Announce..

euroinvestor.co.uk
1 hr ago 1 related
        

Two former internet service customers of Qwest Communications International, Inc. (“Qwest”) today filed a multi-state class action lawsuit in the United States District Court for the Western District of Washington. The lawsuit...

add comment

Franklin Templeton Investments introduces new fund

banking-business-review.com
3 hrs ago 9 related
        

Franklin Templeton Investments has announced that Franklin Large Cap Equity Fund, a large cap blend fund that seeks long-term growth of principal and income, will now be available to retail investors.

add comment

Granite Construction to Announce Third Quarter 2008 Financial Results October 29th

euroinvestor.co.uk
6 hrs ago 4 related
        

Granite Construction Incorporated (NYSE:GVA) announced today that it will release its third quarter 2008 financial results after the close of business on Wednesday, October 29, 2008. The company will host a conference call on...

add comment